LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-12
DOI
10.1186/s13046-018-0947-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- HMGB2 is associated with malignancy and regulates Warburg effect by targeting LDHB and FBP1 in breast cancer
- (2018) Deyuan Fu et al. Cell Communication and Signaling
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- (2018) Claudia Allemani et al. LANCET
- LDHB and FABP4 are Associated With Progression and Poor Prognosis of Pancreatic Ductal Adenocarcinomas
- (2017) Yuan Luo et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Lactate Dehydrogenase B Controls Lysosome Activity and Autophagy in Cancer
- (2016) Lucie Brisson et al. CANCER CELL
- Differential Glutamate Metabolism in Proliferating and Quiescent Mammary Epithelial Cells
- (2016) Jonathan L. Coloff et al. Cell Metabolism
- mTORC1 and mTORC2 in cancer and the tumor microenvironment
- (2016) L C Kim et al. ONCOGENE
- Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors
- (2016) Susi Barollo et al. PLoS One
- A germline predictive signature of response to platinum chemotherapy in esophageal cancer
- (2016) Enrica Rumiato et al. Translational Research
- Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer Cells
- (2016) Bradley Smith et al. Cell Reports
- Suppressed expression of LDHB promotes pancreatic cancer progression via inducing glycolytic phenotype
- (2015) Jiujie Cui et al. MEDICAL ONCOLOGY
- Differential regulation of mTORC1 by leucine and glutamine
- (2015) J. L. Jewell et al. SCIENCE
- Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance
- (2013) Costas A. Lyssiotis et al. CELL CYCLE
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
- (2013) Jaekyoung Son et al. NATURE
- Lactate Dehydrogenase B Is Critical for Hyperactive mTOR-Mediated Tumorigenesis
- (2011) X. Zha et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth
- (2011) D. Gaglio et al. Molecular Systems Biology
- Progesterone and Mifepristone Regulate L-Type Amino Acid Transporter 2 and 4F2 Heavy Chain Expression in Uterine Leiomyoma Cells
- (2009) Xia Luo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
- (2008) D. R. Wise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More